Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
See detailLa fin de la linéarité du dialogue didactique ?
Vromans, Joseph ULg

Conference (1996, May 09)

Detailed reference viewed: 11 (0 ULg)
Full Text
Peer Reviewed
See detailLa fin de la récréation pour l'opérateur historique? Annotation de la décision du Conseil de la concurrence dans l'affaire Belgacom/Scarlet, 7 novembre 2008
Petit, Nicolas ULg; Daems, Ief

in revue de la concurrence belge (2009), (3),

Le Conseil belge de la concurrence a décidé de subordonner l'autorisation de la concentration entre Belgacom et Scarlet à la mise en oeuvre de diverses mesures correctives structurelles et ... [more ▼]

Le Conseil belge de la concurrence a décidé de subordonner l'autorisation de la concentration entre Belgacom et Scarlet à la mise en oeuvre de diverses mesures correctives structurelles et comportementales. [less ▲]

Detailed reference viewed: 96 (1 ULg)
See detailFin de la traversée du désert pour les Fennecs
Cormann, Grégory ULg

Article for general public (2009)

Detailed reference viewed: 22 (3 ULg)
Full Text
Peer Reviewed
See detailLa fin de la vie en médecine intensive
Ferdinande, P.; Berré, J.; Colardyn, F. et al

in Réanimation (2001), 10

Detailed reference viewed: 26 (3 ULg)
Full Text
Peer Reviewed
See detailFin de législature: le point sur l'autonomie fiscale des communautés et des régions
Bourgeois, Marc ULg

in Comptabilité et Fiscalité Pratiques (2003)

Detailed reference viewed: 33 (22 ULg)
Full Text
See detailFin de siècle/Jahrhundertwende: Eine Tendenzgeschichte
Küpper, Achim ULg

in Roland, Hubert (Ed.) Eine kleine deutsch-französische Literaturgeschichte vom 18. Jahrhundert bis zum Ersten Weltkrieg (in press)

Detailed reference viewed: 31 (3 ULg)
Full Text
Peer Reviewed
See detailEl fin de una época: letrados-traductores en la primera colección de literatura traducida del siglo XX en la Argentina
Willson, Patricia ULg

in TRANS : Revista de Traductología (2008), (12), 29-42

The first great collection of books appeared in twentieth century Buenos Aires, «La Biblioteca de La Nación», was composed by 872 titles among which 761 belong to non Hispanic speaking traditions. This ... [more ▼]

The first great collection of books appeared in twentieth century Buenos Aires, «La Biblioteca de La Nación», was composed by 872 titles among which 761 belong to non Hispanic speaking traditions. This article deals with the «figures of translator» built up in the paratexts of this collection. The «learned translators», with political meddling in Argentina and other Latin American countries, especially in the nineteenth century, stand out in those paratexts. [less ▲]

Detailed reference viewed: 40 (20 ULg)
Full Text
See detailLa fin des haricots?
Klaedtke, Stephanie ULg

Conference given outside the academic context (2013)

Afin de répondre aux besoins particuliers des agricultures biologiques et paysannes, paysans et chercheurs s’engagent en partenariat pour faire vivre une diversité de plantes cultivées et réaliser des ... [more ▼]

Afin de répondre aux besoins particuliers des agricultures biologiques et paysannes, paysans et chercheurs s’engagent en partenariat pour faire vivre une diversité de plantes cultivées et réaliser des recherches adaptées. Dans le cadre de cette conférence, nous présentons des projets de sélection participative menés en Bretagne, une des régions pionnières en Europe. Nous discuterons une première démarche de recherche participative faite au Luxembourg et les enjeux de ces recherches. [less ▲]

Detailed reference viewed: 44 (8 ULg)
Full Text
Peer Reviewed
See detailLa fin du certificat de bonnes conduite, vie et mœurs : chronique d’une mort annoncée
Seron, Vincent ULg

in Revue de Droit Pénal et de Criminologie (2007)

Detailed reference viewed: 37 (2 ULg)
See detailLa fin du Mésolithique et le Néolithique au Proche-Orient
Tunca, Önhan ULg

in Le génie de l'Homme. Des origines à l'écriture (1995)

Detailed reference viewed: 14 (1 ULg)
Full Text
Peer Reviewed
See detailFin du Millénaire - fin de l'Agriculture
Schirmer, Jacek; Schmitz, Serge ULg

in Bulletin de la Société Géographique de Liège (1997), 33

Detailed reference viewed: 11 (2 ULg)
See detailLa fin du Paléolithique moyen dans le Nord de l’Europe : la question des origines du Lincombien-Ranisien-Jerzmanowicien
Flas, Damien ULg

in Depaepe, Pascal; Goval, Emilie; Koehler, Héloïse (Eds.) et al Les plaines du Nord-Ouest : carrefour de l’Europe au Paléolithique moyen ? (in press)

Detailed reference viewed: 23 (1 ULg)
See detailLa fin du théologico-politique chez Hobbes et chez Spinoza
Herla, Anne ULg

Conference given outside the academic context (2005)

Detailed reference viewed: 3 (0 ULg)
See detailLa fin'amor, un art d'aimer au Moyen Âge
Henrard, Nadine ULg

Conference given outside the academic context (2006)

Detailed reference viewed: 25 (5 ULg)
Full Text
Peer Reviewed
See detailFinal analysis of overall survival for the Phase III CONFIRM trial: fulvestrant 500 mg versus 250 mg
DI LEO, Angelo; JERUSALEM, Guy ULg; PETRUZELKA, Lubos et al

in Cancer Research. Supplement (2012, December 15), 72(24), 1-4

Detailed reference viewed: 18 (9 ULg)
Full Text
Peer Reviewed
See detailFinal Overall Survival: Fulvestrant 500 mg vs 250 mg in the Randomized CONFIRM Trial.
Leo, Angelo Di; Jerusalem, Guy ULg; Petruzelka, Lubos et al

in Journal of the National Cancer Institute (2014), 106(1), 337

BACKGROUND: At the time of the initial analysis of overall survival (OS) for the Comparison of Faslodex in Recurrent or Metastatic Breast Cancer (CONFIRM) randomized, double-blind, phase III trial ... [more ▼]

BACKGROUND: At the time of the initial analysis of overall survival (OS) for the Comparison of Faslodex in Recurrent or Metastatic Breast Cancer (CONFIRM) randomized, double-blind, phase III trial, approximately 50% of patients had died. A final analysis of OS was subsequently planned for when 75% of patients had died. METHODS: Patients were randomly assigned 1:1 to fulvestrant 500 mg administered as two 5-mL intramuscular injections on days 0, 14, and 28 and every 28 (+/-3) days thereafter or fulvestrant 250 mg administered as two 5-mL intramuscular injections (one fulvestrant and one placebo [identical in appearance to study drug]) on days 0, 14 (two placebo injections only), and 28 and every 28 (+/-3) days thereafter. OS was analyzed using an unadjusted log-rank test. No adjustments were made for multiplicity. Serious adverse events (SAEs) and best response to subsequent therapy were also reported. All statistical tests were two-sided. RESULTS: In total, 736 women (median age = 61.0 years) were randomly assigned to fulvestrant 500mg (n = 362) or 250mg (n = 374). At the final survival analysis, 554 of 736 (75.3%) patients had died. Median OS was 26.4 months for fulvestrant 500mg and 22.3 months for 250mg (hazard ratio = 0.81; 95% confidence interval = 0.69-0.96; nominal P = .02). There were no clinically important differences in SAE profiles between the treatment groups; no clustering of SAEs could be detected in either treatment group. Type of first subsequent therapy and objective responses to first subsequent therapy were well balanced between the two treatment groups. CONCLUSIONS: In patients with locally advanced or metastatic estrogen receptor-positive breast cancer, fulvestrant 500mg is associated with a 19% reduction in risk of death and a 4.1-month difference in median OS compared with fulvestrant 250mg. Fulvestrant 500mg was well tolerated, and no new safety concerns were identified. [less ▲]

Detailed reference viewed: 33 (4 ULg)
See detailFinal Report of the Solar Influences Data Centre Space Weather Pilot Project
Vanlommel, P.; Stegen, Koen; Warnant, René ULg et al

Report (2005)

Detailed reference viewed: 8 (0 ULg)